Abstract
Type 2 diabetes mellitus (T2DM) is a global epidemic disease and has become a significant health problem. Many studies have raised concern about the mild cognitive impairment (MCI) with T2DM and even the Alzheimer’s disease patients with T2DM. The incidence of MCI is higher in individuals with T2DM than those without diabetes. Cognitive changes might affect everyday activities depending on the work and situation. Although the exact pathophysiology of MCI in T2DM is unclear, many studies suggest that the alterations in pathoglycemia, diabetic complications, related end products, and physical/psychological status are significant risk factors. In this article, we systematically overview the studies to illustrate the related risk factors of cognitive impairment in patients with T2DM. Further high quality studies and treatment need to be initiated and it will become incumbent on clinicians to identify and cure the earliest signs of clinical impairment.
References
Abbatecola, A.M., Lattanzio, F., Spazzafumo, L., Molinari, A.M.,Cioffi, M.,Canonico, R.,Dicioccio, L., and Paolisso, G. (2010). Adiposity predicts cognitive decline in older persons with diabetes, a 2-year follow-up. PLoS One 5, e10333.10.1371/journal.pone.0010333Search in Google Scholar PubMed
Barnes, D. and Yaffe, K. (2011). The projected impact of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol. 10, 819–828.10.1016/S1474-4422(11)70072-2Search in Google Scholar
Biessels, G.J., Deary, I.J., and Ryan, C.M. (2008). Cognitive and diabetes, a lifespan perspective. Lancet Neurol. 7, 184–190.10.1016/S1474-4422(08)70021-8Search in Google Scholar PubMed
Blom, H.J. and Smulders, Y. (2011). Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects. J. Inherit. Metab. Dis. 34, 75–81.10.1007/s10545-010-9177-4Search in Google Scholar PubMed PubMed Central
Bosco, D., Fava, A., Plastino, M., Montalcini, T., and Pujia, A. (2011). Possible implications of insulin resistance and glucose metabolism in Alzheimer’s disease pathogenesis. J. Cell Mol. Med. 15, 1807–1821.10.1111/j.1582-4934.2011.01318.xSearch in Google Scholar PubMed PubMed Central
Cai, R., Jing, H., Jie, S., Rong, H., Tian, S., Shen, Y., Dong, X., Xia, W., and Wang, S. (2016). Plasma clusterin and the clu gene rs11136000 variant are associated with mild cognitive impairment in type 2 diabetic patients. Front. Aging Neurosci.8, 179.10.3389/fnagi.2016.00179Search in Google Scholar PubMed PubMed Central
Chen, R.H., Jiang, X.Z., Zhao, X.H., Qin, Y.L., Gu, Z., Gu, P.L., Zhou, B., Zhu, Z.H., Xu, L.Y., and Zou, Y.F. (2012). Risk factors of mild cognitive impairment in middle aged patients with type 2 diabetes: a cross-section study. Ann. Endocrinol. (Paris) 73, 208–212.10.1016/j.ando.2012.04.009Search in Google Scholar PubMed
Cheng, G., Huang, C., Deng, H., and Wang, H. (2012). Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern. Med. J. 42, 484–491.10.1111/j.1445-5994.2012.02758.xSearch in Google Scholar PubMed
Christman, A.L., Matsushita, K., Gottesman, R.F., Mosley, T., Alonso, A., Coresh, J., Hill-Briggs, F., Sharrett, A.R., and Selvin, E. (2011). Glycated haemoglobin and cognitive decline: the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia 54, 1645–1652.10.1007/s00125-011-2095-7Search in Google Scholar PubMed PubMed Central
Chung, C.C., Pimentel, D., Jor’Dan, A.J., Hao, Y., Milberg, W., and Novak, V. (2015). Inflammation-associated declines in cerebral vasoreactivity and cognition in type 2 diabetes. Neurology 85, 450–458.10.1212/WNL.0000000000001820Search in Google Scholar PubMed PubMed Central
Clarke, R., Halsey, J., Bennett, D., and Lewington, S. (2011). Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials. J. Inherit. Metab. Dis. 34, 83–91.10.1007/s10545-010-9235-ySearch in Google Scholar PubMed
Craft, S. (2007). Insulin resistance and Alzheimer’s disease pathogenesis: potential mechanisms and implications for treatment. Curr. Alzheimer Res. 4, 147–152.10.2174/156720507780362137Search in Google Scholar PubMed
Crosby-Nwaobi, R., Sivaprasad, S., and Forbes, A. (2012). A systematic review of the association of diabetic retinopathy and cognitive impairment in people with type 2 diabetes. Diabetes Res. Clin. Pract. 96, 101–110.10.1016/j.diabres.2011.11.010Search in Google Scholar PubMed
Cui, Y., Liang, X., Gu, H., Hu, Y., Zhao, Z., Yang, X.Y., Qian, C, Yang, Y., and Teng, G.J. (2016). Cerebral perfusion alterations in type 2 diabetes and its relation to insulin resistance and cognitive dysfunction. Brain Imaging Behav. 6, 1–10.10.1007/s11682-016-9583-9Search in Google Scholar
Cukierman-Yaffe, T., Gerstein, H.C., Williamson, J.D., Lazar, R.M., Lovato, L., Miller, M.E., Coker, L.H., Murray, A., Sullivan, M.D., Marcovina, S.M., et al. (2009). Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors. Diabetes Care 32, 221–226.10.2337/dc08-1153Search in Google Scholar PubMed
de Luis, D.A., Fernandez, N., Arranz, M., Aller, R., and Izaola, O. (2002). Total homocysteine and cognitive deterioration in people with type 2 diabetes. Diabetes Res. Clin. Pract. 55, 185–190.10.1016/S0168-8227(01)00300-XSearch in Google Scholar PubMed
Deane, R. and Zlokovic, B.V. (2007). Role of the blood-brain barrier in the pathogenesis of Alzheimer’s disease. Curr. Alzheimer Res. 4, 191–197.10.2174/156720507780362245Search in Google Scholar PubMed
Degen, C., Toro, P., Schönknecht, P., Sattler, C., and Schröder, J. (2016). Diabetes mellitus type II and cognitive capacity in healthy aging, mild cognitive impairment and Alzheimer’s disease. Psychiatry Res. 240, 42–46.10.1016/j.psychres.2016.04.009Search in Google Scholar PubMed
Ding, J., Strachan, M.W., Reynolds, R.M., Frier, B.M., Deary, I.J., Fowkes, F.G., Lee, A.J.,McKnight, J., Halpin, P.,Swa, K., et al. (2010). Diabetic retinopathy and cognitive decline in older people with type 2 diabetes. Diabetes 59, 2883–2889.10.2337/db10-0752Search in Google Scholar PubMed PubMed Central
Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E.A.,Frosch, M.P.,Eckman, C.B.,Tanzi, R.E.,Selkoe, D.J., and Guenette, S. (2003). Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo. Proc. Natl Acad. Sci. USA 100, 4162–4167.10.1073/pnas.0230450100Search in Google Scholar PubMed PubMed Central
Ford, A.H., Flicker, L., Hankey, G.J., Norman, P., van Bockxmeer, F.M., and Almeida, O.P. (2011). Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism and cognitive impairment: the health in men study. Mol. Psychiatry 17, 559–566.10.1038/mp.2011.18Search in Google Scholar PubMed PubMed Central
Ford, A.H., Garrido, G.J., Beer, C., Lautenschlager, N.T.,Arnolda, L.,Flicker, L.,and Almeida, O.P. (2012). Homocysteine, grey matter and cognitive function in adults with cardiovascular disease. PLoS One 7, e33345.10.1371/journal.pone.0033345Search in Google Scholar PubMed PubMed Central
Gao, Y., Xiao, Y., Miao, R., Zhao, J.,Cui, M.,Huang, G., andFei, M. (2015). The prevalence of mild cognitive impairment with type 2 diabetes mellitus among elderly people in China: a cross-sectional study. Arch. Gerontol. Geriatr. 62, 138–142.10.1016/j.archger.2015.09.003Search in Google Scholar PubMed
Gasparini, L., Gouras, G.K., Wang, R., Gross, R.S.,Beal, M.F.,Greengard, P.,and Xu, H. (2001). Stimulation of β-amyloid precursor protein trafficking by insulin reduces intraneuronal β-amyloid and requires mitogen-activated protein kinase signaling. J. Neurosci. 21, 2561–2570.10.1523/JNEUROSCI.21-08-02561.2001Search in Google Scholar PubMed
Gorska-Ciebiada, M., Saryuszwolska, M., Borkowska, A., Ciebiada, M.,and Loba, J. (2015). C-Reactive protein, advanced glycation end products, and their receptor in type 2 diabetic, elderly patients with mild cognitive impairment. Front. Aging Neurosci. 29, 209.10.3389/fnagi.2015.00209Search in Google Scholar PubMed PubMed Central
Gorska-Ciebiada, M., Saryusz-Wolska, M., Borkowska, A., Ciebiada, M., and Loba, J. (2016). Adiponectin, leptin and IL-1 β in elderly diabetic patients with mild cognitive impairment. Metab. Brain Dis. 31, 257–266.10.1007/s11011-015-9739-0Search in Google Scholar PubMed PubMed Central
Goveas, J.S., Espeland, M.A., Hogan, P., Dotson, V., Tarima, S., Coker, L.H., Ockene, J., Brunner, R., Woods, N.F., Wassertheil-Smoller, S., et al. (2011). Depressive symptoms, brain volumes and subclinical cerebrovascular disease in postmenopausal women: the women’s health initiative MRI study. J. Affect. Disord. 132, 275–284.10.1016/j.jad.2011.01.020Search in Google Scholar PubMed PubMed Central
Greenwood, C.E., Kaplan, R.J., Hebblethwaite, S., and Jenkins, D.J. (2003). Carbon hydrate induced memory impairment in adults with type 2 diabetes. Diabetes Care 26, 1961–1966.10.2337/diacare.26.7.1961Search in Google Scholar PubMed
Hagger-Johnson, G., Sabia, S., Brunner, E.J., Shipley, M., Bobak, M., Marmot, M., Kivimaki, M., and Singh-Manoux, A. (2013). Combined impact of smoking and heavy alcohol use on cognitive decline in early old age: Whitehall II prospective cohort study. Br. J. Psychiatry 203, 120–125.10.1192/bjp.bp.112.122960Search in Google Scholar PubMed PubMed Central
Heidari Gorji, M.A., Ghahremanlu, H., Haghshenas, M., Sadeghi, M.R., and Heidari Gorji, A.M. (2012). Comparison of memory impairments among two groups of patients with diabetes with different disease durations. BMC Res. Notes 5, 353.10.1186/1756-0500-5-353Search in Google Scholar PubMed PubMed Central
Imamine, R., Kawamura, T., Umemura, T., Umegaki, H.,Kawano, N.,Hotta, M.,Kouchi, Y.,Hatsuda, S.,Watarai, A., Kanai, A., et al. (2011). Does cerebral small vessel disease predict future decline of cognitive function in elderly people with type 2 diabetes? Diabetes Res. Clin. Pract. 94, 91–99.Search in Google Scholar
Infantegarcia, C., Ramosrodriguez, J.J., Galindogonzalez, L., and Garciaalloza, M. (2015). Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer’s disease and type 2 diabetes. Psychoneuroendocrinology65, 15–25.10.1016/j.psyneuen.2015.12.001Search in Google Scholar PubMed
Jiménezpalomares, M., Ramosrodríguez, J.J., Lópezacosta, J.F., Pacheco-Herrero, M., Lechuga-Sancho, A.M., Perdomo, G., García-Alloza, M., and Cózar-Castellano, I. (2012). Increased Aβ production prompts the onset of glucose intolerance and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 302, E1373.10.1152/ajpendo.00500.2011Search in Google Scholar PubMed
Kodl, C.T. and Seaquist, E.R. (2008). Cognitive dysfunction and diabetes mellitus. Endocr. Rev. 29, 494–511.10.1210/er.2007-0034Search in Google Scholar PubMed PubMed Central
Kumano-Kuramochi, M., Ohnishi-Kameyama, M., Xie, Q., Niimi, S., Kubota, F., Komba, S., and Machida, S. (2009). Minimum stable structure of the receptor for advanced glycation end product possesses multi ligand binding ability. Biochem. Biophys. Res. Commun. 386, 130–134.10.1016/j.bbrc.2009.05.142Search in Google Scholar PubMed
Lee, S.M., Koh, D., Fun, S.N., and Sum, C.F. (2010). Diabetes management and hyperglycemia in safety sensitive jobs. Saf. Health Work 2, 9–16.10.5491/SHAW.2011.2.4.380Search in Google Scholar PubMed PubMed Central
Li, W., Wang, T., and Xiao, S. (2016). Type 2 diabetes mellitus might be a risk factor for mild cognitive impairment progressing to Alzheimer’s disease. Neuropsychiatr. Dis. Treat. 12, 2489–2495.10.2147/NDT.S111298Search in Google Scholar PubMed PubMed Central
Liu, W., Ye, P., O’Kusky, J.R., and D’Ercole, A.J. (2009). Type 1 insulin-like growth factor receptor signaling is essential for the development of the hippocampal formation and dentate gyrus. J. Neurosci. Res. 87, 2821–2832.10.1002/jnr.22129Search in Google Scholar PubMed
Lowe, G.D.O. (2001). Is sticky blood a treatable determinant of cognitive decline and of dementia? Age Ageing 30, 101–103.10.1093/ageing/30.2.101Search in Google Scholar PubMed
Luchsinger, J.A., Reitz, C., Patel, B., Tang, M.X., Manly, J.J., and Mayeux, R. (2007). Relation of diabetes to mild cognitive impairment. Arch. Neurol. 64, 570–575.10.1001/archneur.64.4.570Search in Google Scholar PubMed
Malkki, H. (2014). Alzheimer disease: chaperone protein clusterin is involved in amyloid-β-associated entorhinal atrophy in early AD. Nat. Rev. Neurol. 10, 60.10.1038/nrneurol.2014.1Search in Google Scholar PubMed
Marioni, R.E., Stewart, M.C., Murray, G.D., Deary, I.J., Fowkes, F.G., Lowe, G.D., Rumley, A., and Price, J.F. (2009). Peripheral levels of fibrinogen, C-reactive protein, and plasma viscosity predict future cognitive decline in individuals without dementia. Psychosom. Med. 71, 901–906.10.1097/PSY.0b013e3181b1e538Search in Google Scholar PubMed PubMed Central
Marioni, R.E., Deary, I.J., Strachan, M.W., Lowe, G.D., Rumley, A., Murray, G.D., and Price, J.F. (2010). Blood rheology and cognition in the Edinburgh type 2 Diabetes Study. Age Ageing 39, 354–359.10.1093/ageing/afq021Search in Google Scholar PubMed
McNay, E.C., Ong, C.T., McCrimmon, R.J., Cresswell, J., Bogan, J.S., and Sherwin, R.S. (2010). Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance. Neurobiol. Learn. Mem. 93, 546–553.10.1016/j.nlm.2010.02.002Search in Google Scholar PubMed PubMed Central
Mehrabian, S., Raycheva, M., Gateva, A., Todorova, G., Angelova, P., Traykova, M., Stankova, T., Kamenov, Z., and Traykov, L. (2012). Cognitive dysfunction profile and arterial stiffness in type 2 diabetes. J. Neurol. Sci. 322, 152–156.10.1016/j.jns.2012.07.046Search in Google Scholar PubMed
Mi, K. and Johnson, G.V. (2006). The role of tau phosphorylation in the pathogenesis of Alzheimer’s disease. Curr. Alzheimer Res.3, 449–463.10.2174/156720506779025279Search in Google Scholar PubMed
Mogi, M. and Horiuchi, M. (2011). Neurovascular coupling in cognitive impairment associated with diabetes mellitus. Circ. J. 75, 1042–1048.10.1253/circj.CJ-11-0121Search in Google Scholar PubMed
Park, S., Mathis, K.W., and Lee, I.K. (2014). The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases. Rev. Endocr. Metab. Disord. 15, 45–53.10.1007/s11154-013-9275-3Search in Google Scholar PubMed
Patel, S.S., Mehta, V., Changotra, H., and Malairaman, U. (2016). Depression mediates impaired glucose tolerance and cognitive dysfunction: a neuromodulatory role of rosiglitazone. Horm. Behav. 78, 200–210.10.1016/j.yhbeh.2015.11.010Search in Google Scholar PubMed
Petersen, R.C., Smith, G.E., Waring, S.C., Ivnik, R.J., Kokmen, E., and Tangelos, E.G. (1997). Aging, memory, and mild cognitive impairment. Int. Psychogeriatr. 9, 65–69.10.1017/S1041610297004717Search in Google Scholar PubMed
Petersen, R.C., Smith, G.E., Warning, S.C., Ivnik, R.J., Tangalos, E.G., and Kokmen, E. (1999). Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56, 303–308.10.1001/archneur.56.3.303Search in Google Scholar PubMed
Petersen, R.C., Doody, R., Kurz, A., Mohs, R.C.,Morris, J.C.,Rabins, P.V.,Ritchie, K.,Rossor, M., Thal, L., and Winblad, B. (2001). Current concepts in mild cognitive impairment. Arch. Neurol. 58, 1985–1992.10.1001/archneur.58.12.1985Search in Google Scholar PubMed
Petrova, M., Prokopenko, S., Pronina, E., and Mozheyko, E. (2010). Diabetes type 2, hypertension and cognitive dysfunction in middle age women. J. Neurol. Sci. 299, 39–41.10.1016/j.jns.2010.08.057Search in Google Scholar PubMed
Pritchard, S.M., Dolan, P.J., Vitkus, A., and Johnson, G.V. (2011). The toxicity of tau in Alzheimer disease, turnover, targets and potential therapeutics. J. Cell. Mol. Med. 15, 1621–1635.10.1111/j.1582-4934.2011.01273.xSearch in Google Scholar PubMed
Reijmer, Y.D., van den Berg, E., Ruis, C., Kappelle, L.J., and Biessels, G.J. (2010). Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab. Res. Rev. 26, 507–519.10.1002/dmrr.1112Search in Google Scholar PubMed
Richards, R.S. and Nwose, E.U. (2010). Blood viscosity at different stages of diabetes pathogenesis. B. J. Biomed. Sci. 67, 67–70.10.1080/09674845.2010.11730293Search in Google Scholar
Rizzo, M.R., Marfella, R., Barbieri, M., Boccardi, V., Vestini, F., Lettieri, B., Canonico, S.,and Paolisso, G. (2010). Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients. Diabetes Care 33, 2169–2174.10.2337/dc10-0389Search in Google Scholar PubMed
Roy, S., Kim, N., Desai, A., Komaragiri, M.,Baxi, N.,Jassil, N.,Blessinger, M.,Khan, M.,Cole, R.,Desai, N., et al. (2015). Cognitive function and control of type 2 diabetes mellitus in young adults. N. Am. J. Med. Sci. 7, 220–226.10.4103/1947-2714.157627Search in Google Scholar PubMed
Sheen, Y.J. and Sheu, W.H. (2016). Association between hypoglycemia and dementia in patients with type 2 diabetes. Diabetes Res. Clin. Pract. 116, 279–287.10.1016/j.diabres.2016.04.004Search in Google Scholar PubMed
Steen, E., Terry, B.M., Rivera, E.J., Cannon, J.L., Neely, T.R., Tavares, R., Xu, X.J., Wands, J.R., and de la Monte, S.M. (2005). Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease – is this type 3 diabetes? J. Alzheimers Dis. 7, 63–80.10.3233/JAD-2005-7107Search in Google Scholar PubMed
Stern, Y. (2012). Cognitive reserve in ageing and Alzheimer’s disease. Lancet Neurol. 11, 1006–1012.10.1016/S1474-4422(12)70191-6Search in Google Scholar PubMed
Su, F., Shu, H., Ye, Q., Wang, Z., Xie, C., Yuan, B., Zhang, Z., and Bai, F. (2016). Brain insulin resistance deteriorates cognition by altering the topological features of brain networks Neuroimage Clin. 13, 280–287.Search in Google Scholar PubMed
Suzuki, M. (2006). Factors associated with cognitive impairment in elderly patients with diabetes mellitus. J. Am. Geriatr. Soc. 54, 558–559.10.1111/j.1532-5415.2006.00643_11.xSearch in Google Scholar PubMed
Talbot, K., Wang, H.Y., Kazi, H., Han, L.Y., Bakshi, K.P., Stucky, A., Fuino, R.L., Kawaguchi, K.R., Samoyedny, A.J., Wilson, R.S., et al. (2012). Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J. Clin. Invest. 122, 1316–1338.10.1172/JCI59903Search in Google Scholar PubMed PubMed Central
Tansey, M.G., Mccoy, M.K., and Frankcannon, T.C. (2007). Neuroinflammatory mechanisms in Parkinson’s disease, potential environmental triggers, pathways, and targets for early therapeutic intervention. Exp. Neurol. 208, 1–25.10.1016/j.expneurol.2007.07.004Search in Google Scholar PubMed PubMed Central
Tian, S., Han, J., Huang, R., Xia, W., Sun, J., Cai, R., Dong, X., Shen, Y., and Wang, S. (2016). Association of increased serum ACE activity with logical memory ability in type 2 diabetic patients with mild cognitive impairment. Front. Behav. Neurosci. 10, 239.10.3389/fnbeh.2016.00239Search in Google Scholar PubMed PubMed Central
Toro, P., Schonknecht, P., and Schroder, J. (2009). Type II diabetes in mild cognitive impairment and Alzheimer’s disease: results from a prospective population-based study in Germany. J. Alzheimers Dis. 16, 687–691.10.3233/JAD-2009-0981Search in Google Scholar PubMed
Ulrich, P. and Cerami, A. (2001). Protein glycation, diabetes, and aging. Recent Prog. Horm. Res. 56, 1–21.10.1210/rp.56.1.1Search in Google Scholar PubMed
Umegaki, H., Iimuro, S., Shinozaki, T., Araki, A., Sakurai, T., Iijima, K., Ohashi, Y., Ito, H., and Japanese ElderlyDiabetes Intervention Trial Study Group. (2012). Risk factors associated with cognitive decline in the elderly with type 2 diabetes: pooled logistic analysis of a 6-year observation in the Japanese Elderly Diabetes Intervention Trial. Geriatr. Gerontol. Int. 12, 110–116.10.1111/j.1447-0594.2011.00818.xSearch in Google Scholar PubMed
Valente, T., Gella, A., Fernàndez-Busquets, X., Unzeta, M., and Durany, N. (2010). Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer’s disease and diabetes mellitus. Neurobiol. Dis. 37, 67–76.10.1016/j.nbd.2009.09.008Search in Google Scholar PubMed
Wang, P., Huang, R., Lu, S., Xia, W., Cai, R., Sun, H., and Wang, S. (2016). RAGE and AGEs in mild cognitive impairment of diabetic patients: a cross-sectional study. PLoS One 11, e0145521.10.1371/journal.pone.0145521Search in Google Scholar PubMed PubMed Central
Watari, K., Letomendi, A., Elderkin-Thompton, V., Haroon, E., Miller, J., Darwin, C., and Kumar, A. (2006). Cognitive function in adults with type 2 diabetes and major depression. Arch. Clin. Neuropsychol. 21, 787–796.10.1016/j.acn.2006.06.014Search in Google Scholar PubMed
Whitmer, R.A., Karter, A.J., Yaffe, K., Quesenberry, C.P., and Selbt, J.V. (2009). Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. J. Am. Med. Assoc. 301, 1565–1572.10.1001/jama.2009.460Search in Google Scholar PubMed PubMed Central
Win, M.T., Yamamoto, Y., Munesue, S., Saito, H., Han, D., Motoyoshi, S., Kamal, T., Ohara, T., Watanabe, T., and Yamamoto, H. (2012). Regulation of RAGE for attenuating progression of diabetic vascular complications. Exp. Diabetes Res. 2012, 894605.10.1155/2012/894605Search in Google Scholar PubMed PubMed Central
Wu, J.W., Hussaini, S.A., Bastille, I.M., Rodriguez, G.A., Mrejeru, A., Rilett, K., Sanders, D.W., Cook, C., Fu, H., Boonen, R.A., et al. (2016). Neuronal activity enhances tau propagation and tau pathology in vivo. Nat. Neurosci. 19, 1085–1092.10.1038/nn.4328Search in Google Scholar PubMed PubMed Central
Xie, L., Helmerhorst, E., Taddei, K., Plewright, B., Van Bronswijk, W., and Martins, R. (2002). Alzheimer’s β-amyloid peptides compete for insulin binding to the insulin receptor. J. Neurosci. 22, RC221.10.1523/JNEUROSCI.22-10-j0001.2002Search in Google Scholar PubMed
Xu, Z.P., Yang, S.L., Zhao, S., Zheng, C.H., Li, H.H., Zhang, Y., Huang, R.X., Li, M.Z., Gao, Y., Zhang, S.J., et al. (2016). Biomarkers for early diagnostic of mild cognitive impairment in type-2 diabetes patients: a multicentre, retrospective, nested case-control study. eBiomedicine 5, 105–113.10.1016/j.ebiom.2016.02.014Search in Google Scholar PubMed PubMed Central
Yaffe, K., Falvey, C., Hamilton, N., Schwartz, A.V., Simonsick, E.M., Satterfield, S., Cauley, J.A., Rosano, C., Launer, L.J., Strotmeyer, E.S., et al. (2012). Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch. Neurol. 69, 1170–1175.10.1001/archneurol.2012.1117Search in Google Scholar PubMed PubMed Central
Zhong, Y., Miao, Y., Jia, W.P., Yan, H., Wang, B.Y., and Jin, J. (2012a). Hyperinsulinemia, insulin resistance and cognitive decline in older cohort. Biomed. Environ. Sci. 25, 8–14.Search in Google Scholar
Zhong, Y., Zhang, X.Y., Miao, Y., Zhu, J.H., Yan, H., Wang, B.Y., Jin, J., Hu, T.J., and Jia, W.P. (2012b). The relationship between glucose excursion and cognitive function in aged type 2 diabetes patients. Biomed. Environ. Sci. 25, 1–7.Search in Google Scholar
Zhu, X., Smith, M.A., Honda, K., Aliev, G., Moreira, P.I., Nunomura, A., Casadesus, G., Harris, P.L., Siedlak, S.L., and Perry, G. (2007). Vascular oxidative stress in Alzheimer disease. J. Neurol. Sci. 257, 240–246.10.1016/j.jns.2007.01.039Search in Google Scholar PubMed PubMed Central
©2017 Walter de Gruyter GmbH, Berlin/Boston